Compare TSN & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSN | STE |
|---|---|---|
| Founded | 1935 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Meat/Poultry/Fish | Industrial Specialties |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 25.9B |
| IPO Year | N/A | 1992 |
| Metric | TSN | STE |
|---|---|---|
| Price | $59.84 | $251.24 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 9 |
| Target Price | $62.00 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 3.3M | 600.7K |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.40% | 1.00% |
| EPS Growth | N/A | ★ 59.39 |
| EPS | 1.33 | ★ 6.97 |
| Revenue | ★ $54,441,000,000.00 | $5,702,415,000.00 |
| Revenue This Year | $4.28 | $9.61 |
| Revenue Next Year | $0.76 | $6.23 |
| P/E Ratio | $45.12 | ★ $36.17 |
| Revenue Growth | 2.12 | ★ 7.08 |
| 52 Week Low | $50.56 | $200.98 |
| 52 Week High | $64.36 | $268.60 |
| Indicator | TSN | STE |
|---|---|---|
| Relative Strength Index (RSI) | 69.00 | 42.03 |
| Support Level | $55.40 | $256.63 |
| Resistance Level | $58.67 | $261.45 |
| Average True Range (ATR) | 1.39 | 4.93 |
| MACD | 0.24 | -1.82 |
| Stochastic Oscillator | 93.26 | 10.41 |
Tyson Foods is a protein-focused food producer, selling raw chicken, beef, pork, and prepared foods. Chicken and beef are its two largest segments, each composing about one third of US sales. Prepared foods constituted 18% of fiscal 2024 sales and include brands like Tyson, Jimmy Dean, Hillshire Farm, Ball Park, and Sara Lee. However, most of these are in product categories rife with competition where Tyson does not have a massive market share lead. Tyson sells some products overseas, but the international segment accounts for just 4% of total revenue. The company is an active acquirer, with more recent years' purchases focused on international and food-service markets.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.